- Home
- CTSO vs EURK Comparison
CTSO vs EURK Comparison
Compare CTSO & EURK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- EURK
- Stock Information
- Founded
- CTSO 1997
- EURK 2023
- Country
- CTSO United States
- EURK Hong Kong
- Employees
- CTSO N/A
- EURK N/A
- Industry
- CTSO Medical/Dental Instruments
- EURK
- Sector
- CTSO Health Care
- EURK
- Exchange
- CTSO Nasdaq
- EURK NYSE
- Market Cap
- CTSO 68.2M
- EURK 80.0M
- IPO Year
- CTSO N/A
- EURK 2024
- Fundamental
- Price
- CTSO $0.87
- EURK $10.41
- Analyst Decision
- CTSO Strong Buy
- EURK
- Analyst Count
- CTSO 3
- EURK 0
- Target Price
- CTSO $4.67
- EURK N/A
- AVG Volume (30 Days)
- CTSO 138.6K
- EURK 1.7K
- Earning Date
- CTSO 05-14-2025
- EURK 01-01-0001
- Dividend Yield
- CTSO N/A
- EURK N/A
- EPS Growth
- CTSO N/A
- EURK N/A
- EPS
- CTSO N/A
- EURK N/A
- Revenue
- CTSO $35,594,520.00
- EURK N/A
- Revenue This Year
- CTSO $18.72
- EURK N/A
- Revenue Next Year
- CTSO $19.75
- EURK N/A
- P/E Ratio
- CTSO N/A
- EURK N/A
- Revenue Growth
- CTSO 14.51
- EURK N/A
- 52 Week Low
- CTSO $0.70
- EURK $10.03
- 52 Week High
- CTSO $1.61
- EURK $10.41
- Technical
- Relative Strength Index (RSI)
- CTSO 34.05
- EURK N/A
- Support Level
- CTSO $0.87
- EURK N/A
- Resistance Level
- CTSO $1.16
- EURK N/A
- Average True Range (ATR)
- CTSO 0.06
- EURK 0.00
- MACD
- CTSO -0.02
- EURK 0.00
- Stochastic Oscillator
- CTSO 0.34
- EURK 0.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About EURK EUREKA ACQUISITION CORP
Eureka Acquisition Corp is a newly incorporated blank check company.